Latest Sun Pharmaceutical Industries News
Stay Informed on Sun Pharmaceutical Industries Stock News: Access the latest Sun Pharmaceutical Industries stock news, industry updates, and quick information on Sun Pharmaceutical Industries stock buybacks,Sun Pharmaceutical Industries results, Sun Pharmaceutical Industries company analysis, Sun Pharmaceutical Industries live prices, Sun Pharmaceutical Industries dividends, Sun Pharmaceutical Industries bonus share, board meetings, lifetime highs, Sun Pharmaceutical Industries targets, lows, and growth stories with AI—all in one place.
The Economic Times
Deals & disputes drive India Inc legal spends up by 17% in FY24; RIL & Sun Pharma top spenders
Legal expenses for India's top 500 companies rose by 17% in the last fiscal year, driven by international deal activities, dispute resolution costs, and increased compliance. The Nifty 500 companies spent ₹52,568 crore on legal fees. The top spenders included Reliance Industries and Sun Pharmaceutical Industries.
•
Wed, Sep 4, 2024
The Economic Times
Sun Pharma inks pact with Takeda to introduce gastrointestinal drug in India
Sun Pharmaceutical Industries announced a licensing deal with Takeda Pharmaceutical to market Vonoprazan, a novel gastrointestinal drug, in India. The agreement allows Sun Pharma to commercialize 10 mg and 20 mg tablets of Vonoprazan, an innovative treatment for acid peptic disorders, under a non-exclusive patent license.
•
Fri, Jun 21, 2024